The Computerized Cognitive Composite (C3) in A4, an Alzheimer’s Disease Secondary Prevention Trial

BACKGROUND: Computerized cognitive assessments may improve Alzheimer’s disease (AD) secondary prevention trial efficiency and accuracy. However, they require validation against standard outcomes and relevant biomarkers. OBJECTIVE: To assess the feasibility and validity of the tablet-based Computeriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, K.V., Rentz, D.M., Maruff, P., Sun, C.-K., Raman, R., Donohue, M.C., Schembri, A., Stark, C., Yassa, M.A., Wessels, A.M., Yaari, R., Holdridge, K.C., Aisen, P.S., Sperling, R.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755110/
https://www.ncbi.nlm.nih.gov/pubmed/33336226
http://dx.doi.org/10.14283/jpad.2020.38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755110/
https://www.ncbi.nlm.nih.gov/pubmed/33336226
http://dx.doi.org/10.14283/jpad.2020.38

Ejemplares similares